JP2012046484A5 - - Google Patents

Download PDF

Info

Publication number
JP2012046484A5
JP2012046484A5 JP2011145396A JP2011145396A JP2012046484A5 JP 2012046484 A5 JP2012046484 A5 JP 2012046484A5 JP 2011145396 A JP2011145396 A JP 2011145396A JP 2011145396 A JP2011145396 A JP 2011145396A JP 2012046484 A5 JP2012046484 A5 JP 2012046484A5
Authority
JP
Japan
Prior art keywords
salt
loxoprofen
pharmaceutical composition
ambroxol
bromhexine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011145396A
Other languages
Japanese (ja)
Other versions
JP2012046484A (en
JP5238857B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2011145396A priority Critical patent/JP5238857B2/en
Priority claimed from JP2011145396A external-priority patent/JP5238857B2/en
Publication of JP2012046484A publication Critical patent/JP2012046484A/en
Publication of JP2012046484A5 publication Critical patent/JP2012046484A5/ja
Application granted granted Critical
Publication of JP5238857B2 publication Critical patent/JP5238857B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (13)

ロムヘキシン又はその塩、及びアンブロキソール又はその塩からなる群より選ばれる1種以上と、ロキソプロフェン又はその塩とを実質的に互いに接しないように含有する医薬組成物。 Bed Romuhekishin or a salt thereof and ambroxol or with one or more selected from a salt thereof or Ranaru group, pharmaceutical compositions containing such substantially contact with each other and loxoprofen or a salt thereof. ロキソプロフェン又はその塩が、ロキソプロフェンナトリウム水和物である請求項記載の医薬組成物。 Loxoprofen or a salt thereof, a pharmaceutical composition of claim 1 wherein the Loxoprofensodium hydrate. ロキソプロフェン又はその塩を、ロキソプロフェンナトリウム無水物換算で、10〜300mgを1日量として含有する請求項1又は2記載の医薬組成物。 The pharmaceutical composition according to claim 1 or 2 , wherein loxoprofen or a salt thereof is contained in an amount of 10 to 300 mg per day in terms of anhydrous loxoprofen sodium. ブロムヘキシン又はその塩が、ブロムヘキシン塩酸塩である請求項1〜3いずれか1項記載の医薬組成物。The pharmaceutical composition according to any one of claims 1 to 3, wherein the bromhexine or a salt thereof is bromhexine hydrochloride. アンブロキソール又はその塩が、アンブロキソール塩酸塩である請求項1〜4いずれか1項記載の医薬組成物。The pharmaceutical composition according to any one of claims 1 to 4, wherein the ambroxol or a salt thereof is ambroxol hydrochloride. ブロムヘキシン又はその塩を、ブロムヘキシン塩酸塩換算で、0.1〜50mgを1日量として含有する請求項1〜5いずれか1項記載の医薬組成物。The pharmaceutical composition according to any one of claims 1 to 5, which contains 0.1 to 50 mg of bromhexine or a salt thereof as a daily dose in terms of bromhexine hydrochloride. アンブロキソール又はその塩を、アンブロキソール塩酸塩換算で、0.1〜150mgを1日量として含有する請求項1〜6いずれか1項記載の医薬組成物。The pharmaceutical composition according to any one of claims 1 to 6, which contains 0.1 to 150 mg of ambroxol or a salt thereof in terms of ambroxol hydrochloride as a daily dose. ロキソプロフェン又はその塩が、ロキソプロフェン又はその塩を含有する粒状物である請求項1〜7いずれか1項記載の医薬組成物。   The pharmaceutical composition according to any one of claims 1 to 7, wherein the loxoprofen or a salt thereof is a granular material containing loxoprofen or a salt thereof. ブロムヘキシン又はその塩、及びアンブロキソール又はその塩からなる群より選ばれる1種以上が、ブロムヘキシン又はその塩、及びアンブロキソール又はその塩からなる群より選ばれる1種以上を含有する粒状物である請求項1〜8いずれか1項記載の医薬組成物。 One or more selected from the group consisting of bromhexine or a salt thereof and ambroxol or a salt thereof is a granular material containing one or more selected from the group consisting of bromhexine or a salt thereof and ambroxol or a salt thereof A pharmaceutical composition according to any one of claims 1 to 8. (A)ロキソプロフェン若しくはその塩そのもの、又はロキソプロフェン若しくはその塩を含有する固形組成物と、(B)ブロムヘキシン若しくはその塩そのもの、又はブロムヘキシン若しくはその塩を含有する固形組成物とを含有し、これらの固形組成物を構成する成分によって、ロキソプロフェン又はその塩とブロムヘキシン又はその塩とが互いに接しないように配置されている医薬組成物(但し、成分(A)がロキソプロフェン又はその塩そのものであり、かつ成分(B)がブロムヘキシン又はその塩そのものである場合を除く)。(A) Loxoprofen or a salt thereof itself, or a solid composition containing loxoprofen or a salt thereof, and (B) bromhexine or a salt thereof itself, or a solid composition containing bromhexine or a salt thereof, and these solids A pharmaceutical composition in which loxoprofen or a salt thereof and bromhexine or a salt thereof are arranged so as not to contact each other depending on the components constituting the composition (provided that component (A) is loxoprofen or a salt thereof itself and the component ( Except when B) is bromhexine or a salt thereof). (A)ロキソプロフェン若しくはその塩そのもの、又はロキソプロフェン若しくはその塩を含有する固形組成物と、(B)アンブロキソール若しくはその塩そのもの、又はアンブロキソール若しくはその塩を含有する固形組成物とを含有し、これらの固形組成物を構成する成分によって、ロキソプロフェン又はその塩とアンブロキソール又はその塩とが互いに接しないように配置されている医薬組成物(但し、成分(A)がロキソプロフェン又はその塩そのものであり、かつ成分(B)がアンブロキソール又はその塩そのものである場合を除く)。(A) Loxoprofen or a salt thereof itself, or a solid composition containing loxoprofen or a salt thereof, and (B) ambroxol or a salt thereof, or a solid composition containing ambroxol or a salt thereof. The pharmaceutical composition in which loxoprofen or a salt thereof and ambroxol or a salt thereof are arranged so as not to contact each other depending on the components constituting these solid compositions (provided that component (A) is a loxoprofen or a salt thereof itself) And the component (B) is ambroxol or a salt thereof). 固形製剤である請求項1〜11いずれか1項記載の医薬組成物。 The pharmaceutical composition according to any one of claims 1 to 11, which is a solid preparation. 剤形が、カプセル剤、丸剤、顆粒剤、細粒剤、散剤又は錠剤である請求項1〜12いずれか1項記載の医薬組成物。 The pharmaceutical composition according to any one of claims 1 to 12 , wherein the dosage form is a capsule, pill, granule, fine granule, powder or tablet.
JP2011145396A 2010-06-30 2011-06-30 Loxoprofen-containing pharmaceutical composition Active JP5238857B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011145396A JP5238857B2 (en) 2010-06-30 2011-06-30 Loxoprofen-containing pharmaceutical composition

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2010149061 2010-06-30
JP2010149115 2010-06-30
JP2010149115 2010-06-30
JP2010149089 2010-06-30
JP2010149061 2010-06-30
JP2010149089 2010-06-30
JP2010170642 2010-07-29
JP2010170600 2010-07-29
JP2010170642 2010-07-29
JP2010170600 2010-07-29
JP2011145396A JP5238857B2 (en) 2010-06-30 2011-06-30 Loxoprofen-containing pharmaceutical composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013010266A Division JP2013067667A (en) 2010-06-30 2013-01-23 Loxoprofen-containing phermaceutical composition

Publications (3)

Publication Number Publication Date
JP2012046484A JP2012046484A (en) 2012-03-08
JP2012046484A5 true JP2012046484A5 (en) 2013-03-14
JP5238857B2 JP5238857B2 (en) 2013-07-17

Family

ID=45901785

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011145396A Active JP5238857B2 (en) 2010-06-30 2011-06-30 Loxoprofen-containing pharmaceutical composition
JP2013010266A Pending JP2013067667A (en) 2010-06-30 2013-01-23 Loxoprofen-containing phermaceutical composition
JP2013182747A Active JP5571237B2 (en) 2010-06-30 2013-09-04 Loxoprofen-containing pharmaceutical composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013010266A Pending JP2013067667A (en) 2010-06-30 2013-01-23 Loxoprofen-containing phermaceutical composition
JP2013182747A Active JP5571237B2 (en) 2010-06-30 2013-09-04 Loxoprofen-containing pharmaceutical composition

Country Status (1)

Country Link
JP (3) JP5238857B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5624367B2 (en) * 2009-05-28 2014-11-12 興和株式会社 Loxoprofen-containing pharmaceutical preparation
JP6517575B2 (en) * 2015-04-21 2019-05-22 ライオン株式会社 Stacked tablets
JP7098008B2 (en) * 2021-02-02 2022-07-08 ライオン株式会社 Laminated tablets and their manufacturing methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033704A1 (en) * 1995-04-26 1996-10-31 Taisho Pharmaceutical Co., Ltd. Preparation for oral administration
JP4357016B2 (en) * 1998-11-06 2009-11-04 第一三共株式会社 Pharmaceutical composition containing loxoprofen
JP4828707B2 (en) * 2000-02-28 2011-11-30 武田薬品工業株式会社 Solid compression formulation
EP1815852B1 (en) * 2004-11-05 2017-01-25 Lead Chemical Co. Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal antiflammatory analgesic
JP4853818B2 (en) * 2005-08-24 2012-01-11 大正製薬株式会社 Solid formulation containing ibuprofen and ambroxol hydrochloride
JP5465824B2 (en) * 2006-03-24 2014-04-09 第一三共ヘルスケア株式会社 Pharmaceutical preparation and method for producing the same
KR101488804B1 (en) * 2006-12-06 2015-02-04 니프로 패치 가부시키가이샤 Pharmaceutical composition for external application and adhesive skin patch
JP5232520B2 (en) * 2007-04-17 2013-07-10 第一三共ヘルスケア株式会社 Anti-adenoviral agent containing loxoprofen

Similar Documents

Publication Publication Date Title
JP2012031147A5 (en)
JP2012031131A5 (en)
JP2012158592A5 (en)
JP2016065086A5 (en)
IL283152B1 (en) High dose tetracyclic compound containing compositions methods of producing same and uses thereof
JP2014005302A5 (en)
RU2641198C3 (en) COMPOSITIONS OF GLP-1 PEPTIDES AND THEIR PREPARATION
JP2011068653A5 (en)
CY1115652T1 (en) DOSAGE FORM THAT CONTAINS TWO ACTIVE MEDICINAL MIXING INGREDIENTS IN DIFFERENT NATURAL FORMS
JP2012533559A5 (en)
EA200801926A1 (en) TABLETS OF PARACETAMOL WITH FAST DELIVERY
JP2008516004A5 (en)
RU2014115287A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND METHOD FOR PRODUCING IT
JP2012519201A5 (en)
JP2009505991A5 (en)
JP2006342148A5 (en)
JP2014527506A5 (en)
JP2012046484A5 (en)
JP2016515550A5 (en)
JP2012505830A5 (en)
JP2011068692A5 (en)
RU2015113031A (en) The use of 3-n-butyl isoindoline ketones in the preparation of medicines for the prevention and treatment of cerebral infarction
JP2015120758A5 (en)
HRP20220701T1 (en) Fused benzazepines for treatment of tourette's syndrome
JP2013032353A5 (en)